267
Participants
Start Date
June 30, 2010
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Aliskiren (6.25/12.5/25 mg)
Aliskiren dispensing capsules containing minitablets (3.125 mg per minitablet). For the low dose arm, participants used one or more of the 6.25 mg capsule (containing 2 minitablets) once daily to reach the body-weight stratified dose of aliskiren.
Aliskiren (37.5/75/150 mg)
Aliskiren dispensing capsules containing minitablets (3.125 mg per minitablet). For the medium dose arm, participants used one or more of the 37.5 mg capsule (containing 12 minitablets) once daily to reach the body- weight stratified dose of aliskiren.
Aliskiren (150/300/600 mg)
Aliskiren dispensing capsules containing minitablets (3.125 mg per minitablet). For the high dose arm, participants used one or more of the 150 mg capsule (containing 48 minitablets) once daily to reach the body- weight stratified dose of aliskiren.
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Edegem
Novartis Investigative Site, Leuven
Novartis Investigative Site, Miskolc
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Nyíregyháza
Novartis Investigative Site, Szeged
Novartis Investigative Site, Ghent
Novartis Investigative Site, New York
Novartis Investigative Site, Pittsburgh
Novartis Investigative Site, Charleston
Novartis Investigative Site, Charleston
Novartis Investigative Site, Atlanta
Novartis Investigative Site, Dalton
Novartis Investigative Site, Pensacola
Novartis Investigative Site, Marburg
Novartis Investigative Site, Izmir
Novartis Investigative Site, Jackson
Novartis Investigative Site, Hattiesburg
Novartis Investigative Site, Louisville
Novartis Investigative Site, Columbus
Novartis Investigative Site, Toledo
Novartis Investigative Site, Park Ridge
Novartis Investigative Site, Little Rock
Novartis Investigative Site, Amarillo
Novartis Investigative Site, Lewiston
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Myjava
Novartis Investigative Site, Trnava
Novartis Investigative Site, San Diego
Novartis Investigative Site, Portland
Novartis Investigative Site, Portland
Novartis Investigative Site, Seattle
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Hackensack
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Veszprém
Novartis Investigative Site, Warsaw
Novartis Investigative Site, San Juan
Novartis Investigative Site, Martin
Novartis Investigative Site, Prešov
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY